Peptide Synthesis Market Global Industry Overview and Competitive Landscape till 2032

According to Future Market Insights’ (FMI) peptide synthesis market survey, the peptide synthesis market is expected to grow at a CAGR of 7% between 2022 and 2032.

The prevalence of a wide range of peptide applications in the treatment of various lifestyle disorders, such as cancer, diabetes, and obesity, has a significant impact on market growth.

Peptide synthesis in pharmaceutical manufacturing is increasingly being considered as active in drug development due to their large chemical space, high biological activity, and low toxicity, which is expected to flourish the peptide synthesis market and increase the adoption of the peptide synthesis process. Peptides generate billions of dollars in revenue across multiple therapeutic areas, including oncology, diabetes, and obesity.

Because of the COVID-19 pandemic, major pharmaceutical and biotechnology companies, as well as peptide synthesis companies, have increased their investments in therapeutic and peptide-based vaccine research and development. Peptide synthesis has also risen to prominence as a result of increased demand for peptide synthesis drugs and vaccines. The peptide-based approach is significant because peptides have demonstrated distinct selectivity and specificity toward specific targets.

To remain ‘ahead’ of your competitors, request for a sample @ 
https://www.futuremarketinsights.com/reports/sample/REP-GB-14257

CoVac-1 is a peptide-based vaccine candidate that combines SARS-CoV-2 T-cell epitopes derived from various viral proteins with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG in order to induce profound SARS-CoV-2 T-cell immunity against COVID-19. Such advancements have resulted in an emerging trend in the peptide synthesis market, which has increased demand for reagents and equipment used in peptide production.

Because of the lack of a unified set of regulations, obtaining approvals for therapeutic peptides has been difficult, limiting their application areas. This is regarded as a major impediment to the global peptide synthesis market’s growth. Taking into account all of the aforementioned factors, the peptide synthesis market is expected to be worth around US$ 720 Mn by 2026.

Key Takeaways

• Peptide synthesis market future trends suggests that the market is anticipated to be dominated by the reagents segment.
• The historical performance of the peptide synthesis market was modest with the valuation of US$ 514 in 2021.
• The APAC peptide synthesis market is expected to continue to grow at the fastest rate, owing to increased investments by pharmaceutical as well as increased R&D activities in the region’s countries.
• Based on end use, pharmaceutical and biotechnology companies are expected to hold a significant market share due to the increasing use of peptides for therapeutic drug development.
• By technology, the segment of solid-phase peptide synthesis is expected to advance at faster pace due to ease of peptide purification.

“High prevalence of chronic diseases, and increased investments in the development of structure-based drug designs can all be attributed to North America’s large peptide synthesis market share as the rising number of cancer cases is expected to drive peptide synthesis market growth and as per the World Health Organization article, 18.1 million new cancer cases are reported worldwide each year. Add to that the demand for immunity-boosting drugs in the times of COVID-19 and the market potential seems conducive.” says an FMI analyst.

Competitive Landscape:

The following companies dominate the global peptide synthesis market:

Among those involved are CEM Corporation, Merck KGaA, PuroSynth, Syngene, Lonza, GenScript Biotech Corporation, Novo Nordisk A/S, Bachem Holding AG, ThermoFisher Scientific Inc., Gyros Protein Technologies, Creative Diagnostics, Biotage AB, and AAPPTec.

Some peptide synthesis companies are increasing their market share through various strategies such as acquisitions, mergers, and research collaborations, while others are maintaining their market share through the introduction of new products.

For critical insights, request for PDF Brochure @
https://www.futuremarketinsights.com/reports/brochure/rep-gb-14257

Key Segments

By  Product and Service:

• Reagents
• Equipment
• Services

By Technology:

• Solid-Phase Peptide Synthesis
• Solution-Phase Peptide synthesis
• Hybrid & Recombinant Technology

By End Use:

• Pharmaceuticals & Biotechnology Companies
• CDMOs & CROs
• Academics & Research Institutes

By Region:

• North America
• Latin America
• Europe
• Asia-Pacific excluding Japan
• Middle East & Africa

Key Players:

• GenScript Biotech Corporation
• Bachem Holding AG
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Kaneka Corporation
• Biotage AB
• Syngene International Limited
• Mesa Laboratories, Inc.
• Cem Corporation
• Proteogenix

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/peptide-synthesis-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs